
Lisa Boothe 🇺🇸 @LisaMarieBoothe
@eshap They don’t have a patent and ivermectin is incredibly cheap to make. However, Merck will make bank from this new therapeutic which costs $700 per patient. Maybe you shouldn’t be calling people dumb… https://t.co/gBpZujiQYZ — PolitiTweet.org